# Message test — https://cambrianalliance.co.uk/ After reading your page, only 8 of 15 personas could name a reason to pick you over a similar option. - **Page tested:** https://cambrianalliance.co.uk/ - **Audience tested against:** Community pharmacy owners, 1-20 sites, looking to improve efficiency in ordering - saving time for staff to do more valuable clinical work AND save money on ordering. - **Personas:** 15 simulated - **Report:** https://grader.wynter.com/r/cambrian-alliance-control-your-pharmacy-stock--mzJaOZ8 > These answers are generated by AI, scored on Wynter's B2B Message > Layers framework using behaviorally-diverse simulated personas. The > methodology is real and the critique is directional. What a simulated > persona cannot have is a live budget, a renewal coming up, or a boss > asking about this quarter. --- ## 01 · The scores Every persona answered all four questions. These are four independent proportions of the same panel, not stages of a funnel. | Layer | Question | Cleared the bar | Strength | Of those who passed | | --- | --- | --- | --- | --- | | 1. Clarity | Do they understand what you do? | 14/15 | 82% | 3 without hesitation, 12 with reservations | | 2. Relevance | Can they tell what it solves, and who it's for? | 15/15 | 90% | 8 without hesitation, 7 with reservations | | 3. Value | Do they actually want it? | 15/15 | 78% | all with reservations | | 4. Differentiation | Is there a reason to pick you over the alternatives? | 8/15 | 53% | all with reservations | **Brand alignment** (a side metric, not one of the four layers) — 15/15, 78% strength (all with reservations). Does the page read like the company you actually are? **Fix first: Differentiation.** Earliest failing layer, walking the sequence in order — not simply the lowest score. --- ## 02 · What to change, layer by layer Ordered worst-first. Specific edits, not a restatement of the score. ### Differentiation **Name the wholesalers and PMR systems e-CASS connects to.** "Order via your PMR, e-CASS Web or both" and "across every supplier" name nothing. Buyers judging stack fit need the actual PMR systems and wholesaler names listed on the page. *effort low · impact high · tested against Specifics beat superlatives* **Explain the cascade in one plain sentence where it first appears.** "Our cascade system enables multiple ways to control your ordering" names a mechanism and leaves readers to reverse-engineer it from bullets. State what the cascade does: ranks wholesalers by your rules and routes each line to the cheapest compliant supplier. *effort low · impact high · tested against Plain language* **State where Cambrian sits in the supply chain.** Nothing on the page says whether this is a neutral price comparator or a wholesaler selling its own stock — the difference decides whether the recommendations can be trusted. Add a line stating the company's position and independence from suppliers. *effort low · impact high · tested against Give a reason to choose you* ### Clarity **Add pricing or a pricing model next to the demo CTA.** With no cost anywhere, readers cannot weigh the gain against their existing PMR purchasing. Publish the model — per-site fee, percentage of savings — even if the number is on request. *effort medium · impact medium · tested against Answer the live objection* ### Value **Attach source, timeframe and pharmacy size to the margin claim.** The 5-7% figure arrives with no baseline, sample or period, so it reads as a brochure number. Name the pharmacy type, the measurement window and what it was compared against. *effort low · impact high · tested against Proof next to the claim* ### Brand alignment (side metric) **Add a line for multi-site operators in the opening block.** "Customise your pharmacy's settings" is singular throughout, so group and multi-site buyers read the page as built for one shop. Say how settings, cascades and reporting work across a group. *effort low · impact medium · tested against Name the audience* --- ## 03 · What is working ### The opening lines make the audience and the problem obvious Six respondents said the headline and first two sentences signpost the pain point, the solution and the buyer — independent pharmacy owners and dispensary managers — without effort. > The reader is clearly a pharmacy - the customer quotes are named pharmacists/pharmacies (Nat Mitchell at JWW Allison's Chemist, Mo Nazemi at Evans Pharmacy, Edward Down at a Medical Practice) > > — Pharmacy Manager, Pharmaceuticals, 11-50 > The customer quotes (Nat Mitchell, a chemist; Mo Nazemi, a pharmacy; a dispensary manager talking about generics margins) confirm it's aimed at independent pharmacy owners or dispensary managers like me > > — Pharmacy Business Owner, Pharmaceuticals, 1-10 > Actually it wasn't hard to pin down what it does - I understood the concept fine on first read. If anything the slight friction was words like "cascade" and "e-CASS Web" used before being defined > > — Pharmacy Operations Manager, Pharmaceuticals, 11-50 > the top of the page says "You don't have the time to oversee the endless complexities of ordering stock, you need a system that does the work for you" and then "e-CASS gives you total control over how you buy" - so within the first two lines I knew it's a stock-ordering automation tool > > — Pharmacy Operations Manager, Pharmaceuticals, 11-50 ### Automating manual wholesaler price comparison is the value respondents could repeat back Three respondents restated the core benefit unprompted: the system compares wholesaler price lists, blocks over-tariff ordering and removes weekly manual work. > I'd stop paying someone to manually cross-check wholesaler price lists every week > > — Pharmacy Business Owner, Healthcare, 11-50 > a purchasing/procurement automation tool for pharmacies, aimed at cutting admin time and boosting margins > > — Pharmacy Manager, Pharmaceuticals, 11-50 > It's an automated purchasing/ordering system for pharmacies - something that sits alongside your PMR and manages a "cascade" of wholesaler prices so you're always buying at the cheapest available price, blocking over-tariff orders and tracking margins. > > — Community Pharmacy Owner, Healthcare, 11-50 --- ## 04 · What the personas said ### The cascade mechanism is named but never explained Two respondents said abstract mechanisms like the cascade system are left unpacked and must be inferred from feature bullets, and one flagged the missing list of named wholesalers as critical. > "total control over how you buy", "a whole lot more", and "cascade system" never get unpacked into an actual sequence of what happens when an order pad is built and a rule fires; I had to infer the mechanism from the feature bullets rather than being shown it. > > — Head of Pharmacy Operations, Retail Pharmacy, 11-50 > there's no pricing, no mention of switching effort or PMR compatibility, and no detail on how many wholesalers are actually in the cascade > > — Community Pharmacy Owner, Retail Pharmacy, 1-10 ### The company's own position in the supply chain is unstated Two respondents could not tell whether the company is a neutral wholesaler or owns suppliers, and noted the missing 'About us' section left them inferring the firm's size. > What's missing that would confirm the size/maturity guess is any "About us," headcount, or how long they've operated - right now it's an inference from tone and specificity, not a stated fact > > — Pharmacy Operations Manager, Retail Pharmacy, 1-10 ### That same 5-7% figure is not trusted without methodology, timeframe or sample Six respondents said the single customer claim lacks source, baseline, scale and timeframe, and wanted verified margin uplift from a live trial before committing. Credibility rests entirely on this one unvalidated number. > A verified margin uplift I can attribute directly to the tool - not a self-reported 5-7% from one dispensary, but something I can check against my own purchasing data after a live trial period > > — Pharmacy Business Owner, Healthcare, 11-50 > it's one quote from one dispensary, no scale or timeframe attached, so I'd want to know what happened for a pharmacy my size before I'd believe it applies to me > > — Pharmacy Manager, Pharmaceuticals, 11-50 > A verified, sourced 5-7% profitability uplift with the baseline and sample size disclosed — if that number holds up on a call, it's worth my time; if it's just a quote with no data behind it, it isn't. > > — Pharmacy Operations Manager, Healthcare, 1-10 > Edward Down's quote about profitability rising 5-7% from blocking over-tariff orders is the kind of concrete outcome that would actually matter to my margins. But that number has no source or timeframe > > — Community Pharmacy Owner, Healthcare, 11-50 > The 5-7% profitability claim from the Caythorpe testimonial is the closest thing to proof, but it's a single anecdote with no baseline shown - I'd want to see that across a sample of pharmacies before I believed it applies broadly. > > — Head of Pharmacy Operations, Healthcare, 1-10 ### Multi-site operators do not see themselves in the page Two respondents said the pitch targets single-site owners and never mentions multi-site purchasing, despite that being their key use case. > The tone is written for a pharmacy owner-operator who's also doing the dispensing themselves — "you don't have the time to oversee the endless complexities" and the kitchen price-list story — which is close to me but a notch below my level; I'm running purchasing across multiple sites and thinking about margin at a portfolio level, and the page never really speaks to that multi-site reality > > — Head of Pharmacy Operations, Retail Pharmacy, 11-50 > I'd need a line naming multi-site or group purchasing explicitly, something like "manage purchasing rules across all your branches from one dashboard" plus a testimonial from someone running more than one site, not just single-dispensary owners like JWW Allison's or Evans Pharmacy. > > — Head of Pharmacy Operations, Retail Pharmacy, 11-50 ### PMR integration and switching costs are absent, so buyers cannot judge stack fit Five respondents wanted named PMR systems and wholesaler integrations plus switching disruption detail; without them the product reads as a generic pharmacy tool rather than something that fits their stack. > I'd need to see our actual daily wholesalers named in the cascade list, plus a line saying it plugs into the specific PMR we run — right now it's generic enough to apply to any pharmacy, and I want proof it's built for my exact stack, not just "pharmacies" in the abstract. > > — Pharmacy Operations Manager, Healthcare, 1-10 > it just doesn't tell me anything about how e-CASS integrates with my existing PMR setup or switching costs, which is what I'd actually need to know. > > — Community Pharmacy Owner, Healthcare, 11-50 > what would push it further is if it named my specific PMR system by brand, since that's the detail that would tell me they've actually built for my setup and not just pharmacies in general > > — Pharmacy Operations Manager, Pharmaceuticals, 11-50 > no detail on PMR compatibility (which PMR systems does it integrate with - mine specifically?), no mention of switching time or setup disruption, and no pricing shown > > — Pharmacy Manager, Pharmaceuticals, 11-50 > If a competitor's page named their wholesaler panel explicitly and this one doesn't, that gap alone would tip me toward the other option, because "every supplier" with no list attached is exactly the kind of vague claim that burned me before. > > — Pharmacy Operations Manager, Healthcare, 1-10 ### Missing pricing blocks any competitive comparison Three respondents said absent pricing prevents them assessing the incremental gain over their existing PMR purchasing or comparing the product against alternatives. > the real question is whether e-CASS adds meaningfully on top of what I do now rather than just formalising it - the page doesn't tell me the cost or the switching effort > > — Community Pharmacy Owner, Retail Pharmacy, 1-10 > there's no pricing, no mention of switching effort or PMR compatibility, and no detail on how many wholesalers are actually in the cascade > > — Community Pharmacy Owner, Retail Pharmacy, 1-10 > no detail on PMR compatibility (which PMR systems does it integrate with - mine specifically?), no mention of switching time or setup disruption, and no pricing shown > > — Pharmacy Manager, Pharmaceuticals, 11-50 --- ## 05 · The hardest read An adversarial pass over the findings. Every claim below was checked against the panel's own answers; unsupported ones were dropped. - **The page's entire commercial case rests on one number nobody believes.** *(high)* Six of 15 respondents rejected the 5-7% claim for lacking source, baseline, scale and timeframe, with several demanding a live trial first. No other proof point appears anywhere in the themes. - **Buyers can restate the benefit but cannot act on it, so the page generates recall without pipeline.** *(high)* Three respondents repeated the price-comparison benefit unprompted, yet six distrusted the savings figure, five could not judge stack fit and three could not compare on price. Comprehension is not the bottleneck; evidence is. - **The page cannot survive a procurement conversation because every commercial input is missing.** *(high)* Three respondents said absent pricing blocks comparison against existing PMR purchasing, and five wanted named PMR and wholesaler integrations plus switching disruption detail. There is nothing to build a business case from. - **The product reads as generic, which hands the win to any competitor that names systems.** *(high)* Five respondents said that without named PMR systems and wholesaler integrations the product reads as a generic pharmacy tool, and one flagged the missing list of named wholesalers as critical. - **The page hides who is selling, which kills trust before the savings claim is even tested.** *(medium)* Two respondents could not tell whether the company is a neutral wholesaler or owns suppliers, and the missing 'About us' left them guessing at firm size. Neutrality is the core question in a purchasing tool. - **Naming the cascade without explaining it signals insider fluency the page never earns.** *(medium)* Two respondents said abstract mechanisms are left unpacked and must be inferred from feature bullets. A mechanism the reader has to reverse-engineer from bullets is not a differentiator. --- ## 06 · Who answered | # | Role | Industry | Company size | | --- | --- | --- | --- | | 1 | Pharmacy Business Owner | Healthcare | 11-50 | | 2 | Community Pharmacy Owner | Retail Pharmacy | 1-10 | | 3 | Pharmacy Manager | Pharmaceuticals | 11-50 | | 4 | Pharmacy Operations Manager | Healthcare | 1-10 | | 5 | Head of Pharmacy Operations | Retail Pharmacy | 11-50 | | 6 | Pharmacy Business Owner | Pharmaceuticals | 1-10 | | 7 | Community Pharmacy Owner | Healthcare | 11-50 | | 8 | Pharmacy Manager | Retail Pharmacy | 1-10 | | 9 | Pharmacy Operations Manager | Pharmaceuticals | 11-50 | | 10 | Head of Pharmacy Operations | Healthcare | 1-10 | | 11 | Pharmacy Business Owner | Retail Pharmacy | 11-50 | | 12 | Community Pharmacy Owner | Pharmaceuticals | 1-10 | | 13 | Pharmacy Manager | Healthcare | 11-50 | | 14 | Pharmacy Operations Manager | Retail Pharmacy | 1-10 | | 15 | Head of Pharmacy Operations | Pharmaceuticals | 11-50 | --- ## 07 · Before you act on this The methodology is real, and the critique is directional. What a simulated persona cannot have is a live budget, a renewal coming up, or a boss asking about this quarter. **Validate anything you're betting on with real ICPs who are actually in-market.** Being wrong is more expensive than you think. Finding out is cheaper than you'd guess. Wynter runs message testing with verified B2B professionals — trusted by HubSpot, RingCentral, Shopify, Cognism, Paddle, Veeam, Rippling and Miro. This report is kept for 60 days from 2026-08-25, then deleted along with the personas and their answers.